FAP overexpression is associated with poor cancer prognosis (Park et al., 1999; Brennen et al., 2012; Kratochwil et al., 2019) and is, therefore, an excellent biomarker for cancer and an important target for diagnosis and therapeutic applications in nuclear medicine. This evidence concerns the gene FAP and cancer.